SE451328B - 2-substituerade bensofuranderivat, forfarande for deras framstellning samt farmaceutiska kompositioner innehallande nemnda derivat - Google Patents
2-substituerade bensofuranderivat, forfarande for deras framstellning samt farmaceutiska kompositioner innehallande nemnda derivatInfo
- Publication number
- SE451328B SE451328B SE8106733A SE8106733A SE451328B SE 451328 B SE451328 B SE 451328B SE 8106733 A SE8106733 A SE 8106733A SE 8106733 A SE8106733 A SE 8106733A SE 451328 B SE451328 B SE 451328B
- Authority
- SE
- Sweden
- Prior art keywords
- chlorophenyl
- acceptable salt
- pharmaceutically acceptable
- methyl
- benzofuran
- Prior art date
Links
- 238000000034 method Methods 0.000 title claims description 5
- 238000002360 preparation method Methods 0.000 title claims description 5
- 239000008194 pharmaceutical composition Substances 0.000 title claims 2
- 150000003839 salts Chemical class 0.000 claims description 35
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims description 30
- -1 (p-tolyl) methyl Chemical group 0.000 claims description 26
- 150000001875 compounds Chemical class 0.000 claims description 26
- 229910052757 nitrogen Inorganic materials 0.000 claims description 17
- GLUUGHFHXGJENI-UHFFFAOYSA-N Piperazine Chemical compound C1CNCCN1 GLUUGHFHXGJENI-UHFFFAOYSA-N 0.000 claims description 16
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims description 12
- 125000004244 benzofuran-2-yl group Chemical group [H]C1=C(*)OC2=C([H])C([H])=C([H])C([H])=C12 0.000 claims description 11
- 125000003854 p-chlorophenyl group Chemical group [H]C1=C([H])C(*)=C([H])C([H])=C1Cl 0.000 claims description 11
- 150000002576 ketones Chemical class 0.000 claims description 10
- 125000004435 hydrogen atom Chemical group [H]* 0.000 claims description 9
- YNAVUWVOSKDBBP-UHFFFAOYSA-N Morpholine Chemical compound C1COCCN1 YNAVUWVOSKDBBP-UHFFFAOYSA-N 0.000 claims description 8
- 125000000217 alkyl group Chemical group 0.000 claims description 8
- 239000000203 mixture Substances 0.000 claims description 8
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 claims description 6
- PTHGDVCPCZKZKR-UHFFFAOYSA-N (4-chlorophenyl)methanol Chemical compound OCC1=CC=C(Cl)C=C1 PTHGDVCPCZKZKR-UHFFFAOYSA-N 0.000 claims description 5
- 125000004432 carbon atom Chemical group C* 0.000 claims description 4
- FGQZVPZMZJBGIY-UHFFFAOYSA-N (5-bromo-1-benzofuran-2-yl)-phenylmethanol Chemical compound C=1C2=CC(Br)=CC=C2OC=1C(O)C1=CC=CC=C1 FGQZVPZMZJBGIY-UHFFFAOYSA-N 0.000 claims description 3
- 125000003118 aryl group Chemical group 0.000 claims description 3
- 125000005843 halogen group Chemical group 0.000 claims description 3
- 229910052739 hydrogen Inorganic materials 0.000 claims description 3
- 239000001257 hydrogen Substances 0.000 claims description 3
- 125000003386 piperidinyl group Chemical group 0.000 claims description 3
- TWLHPSFRWFCYSN-UHFFFAOYSA-N (4-chlorophenyl)-(4,6-dimethoxy-1-benzofuran-2-yl)methanone Chemical compound O1C2=CC(OC)=CC(OC)=C2C=C1C(=O)C1=CC=C(Cl)C=C1 TWLHPSFRWFCYSN-UHFFFAOYSA-N 0.000 claims description 2
- SVQLTYVFAXKBMP-UHFFFAOYSA-N (4-chlorophenyl)-(5-methoxy-1-benzofuran-2-yl)methanone Chemical compound C=1C2=CC(OC)=CC=C2OC=1C(=O)C1=CC=C(Cl)C=C1 SVQLTYVFAXKBMP-UHFFFAOYSA-N 0.000 claims description 2
- UEULSYKXKYYCOE-UHFFFAOYSA-N (4-chlorophenyl)-(7-ethoxy-1-benzofuran-2-yl)methanone Chemical compound O1C=2C(OCC)=CC=CC=2C=C1C(=O)C1=CC=C(Cl)C=C1 UEULSYKXKYYCOE-UHFFFAOYSA-N 0.000 claims description 2
- BZOIBOMFRASZLR-UHFFFAOYSA-N (4-chlorophenyl)-(7-methoxy-1-benzofuran-2-yl)methanol Chemical compound O1C=2C(OC)=CC=CC=2C=C1C(O)C1=CC=C(Cl)C=C1 BZOIBOMFRASZLR-UHFFFAOYSA-N 0.000 claims description 2
- VLDBYOVWADCHOY-UHFFFAOYSA-N (7-ethoxy-1-benzofuran-2-yl)-(4-nitrophenyl)methanol Chemical compound O1C=2C(OCC)=CC=CC=2C=C1C(O)C1=CC=C([N+]([O-])=O)C=C1 VLDBYOVWADCHOY-UHFFFAOYSA-N 0.000 claims description 2
- FWBUITPOHRMSIN-UHFFFAOYSA-N (7-ethoxy-1-benzofuran-2-yl)-(4-phenylphenyl)methanone Chemical compound O1C=2C(OCC)=CC=CC=2C=C1C(=O)C(C=C1)=CC=C1C1=CC=CC=C1 FWBUITPOHRMSIN-UHFFFAOYSA-N 0.000 claims description 2
- FAUXHPGIOILSKR-UHFFFAOYSA-N 1-(1-benzofuran-2-yl)-1-(4-chlorophenyl)-2-phenylethanol Chemical compound C=1C2=CC=CC=C2OC=1C(C=1C=CC(Cl)=CC=1)(O)CC1=CC=CC=C1 FAUXHPGIOILSKR-UHFFFAOYSA-N 0.000 claims description 2
- YOJWZTMPJRZZNV-UHFFFAOYSA-N 1-(1-benzofuran-2-yl)-1-(4-chlorophenyl)ethanol Chemical compound C=1C2=CC=CC=C2OC=1C(O)(C)C1=CC=C(Cl)C=C1 YOJWZTMPJRZZNV-UHFFFAOYSA-N 0.000 claims description 2
- PQTPKSFIMIGKQG-UHFFFAOYSA-N 1-(4-chlorophenyl)-1-(7-methoxy-1-benzofuran-2-yl)-2-phenylethanol Chemical compound O1C=2C(OC)=CC=CC=2C=C1C(O)(C=1C=CC(Cl)=CC=1)CC1=CC=CC=C1 PQTPKSFIMIGKQG-UHFFFAOYSA-N 0.000 claims description 2
- WBPICCPEFYYUAY-UHFFFAOYSA-N 1-(4-chlorophenyl)-1-(7-methoxy-1-benzofuran-2-yl)ethanol Chemical compound O1C=2C(OC)=CC=CC=2C=C1C(C)(O)C1=CC=C(Cl)C=C1 WBPICCPEFYYUAY-UHFFFAOYSA-N 0.000 claims description 2
- ZKGOMWQUXAQPJO-UHFFFAOYSA-N 1-benzofuran-2-yl-(2-methoxyphenyl)methanone Chemical compound COC1=CC=CC=C1C(=O)C1=CC2=CC=CC=C2O1 ZKGOMWQUXAQPJO-UHFFFAOYSA-N 0.000 claims description 2
- OUQHVCOFXUKHNC-UHFFFAOYSA-N 1-benzofuran-2-yl-(2-methylphenyl)methanol Chemical compound CC1=CC=CC=C1C(O)C1=CC2=CC=CC=C2O1 OUQHVCOFXUKHNC-UHFFFAOYSA-N 0.000 claims description 2
- ARCUPWRDHBYITA-UHFFFAOYSA-N 1-benzofuran-2-yl-(4-phenylphenyl)methanol Chemical compound C=1C2=CC=CC=C2OC=1C(O)C(C=C1)=CC=C1C1=CC=CC=C1 ARCUPWRDHBYITA-UHFFFAOYSA-N 0.000 claims description 2
- XZETVKAQXMPVDF-UHFFFAOYSA-N 1-benzofuran-2-yl-(4-phenylphenyl)methanone Chemical compound C=1C2=CC=CC=C2OC=1C(=O)C(C=C1)=CC=C1C1=CC=CC=C1 XZETVKAQXMPVDF-UHFFFAOYSA-N 0.000 claims description 2
- WVDDGKGOMKODPV-UHFFFAOYSA-N Benzyl alcohol Chemical compound OCC1=CC=CC=C1 WVDDGKGOMKODPV-UHFFFAOYSA-N 0.000 claims description 2
- 125000003545 alkoxy group Chemical group 0.000 claims description 2
- 230000003288 anthiarrhythmic effect Effects 0.000 claims description 2
- 230000001387 anti-histamine Effects 0.000 claims description 2
- 239000003416 antiarrhythmic agent Substances 0.000 claims description 2
- 239000000739 antihistaminic agent Substances 0.000 claims description 2
- 125000003710 aryl alkyl group Chemical group 0.000 claims description 2
- 239000003795 chemical substances by application Substances 0.000 claims description 2
- 125000000068 chlorophenyl group Chemical group 0.000 claims description 2
- 230000008602 contraction Effects 0.000 claims description 2
- 239000003589 local anesthetic agent Substances 0.000 claims description 2
- UFEJKYYYVXYMMS-UHFFFAOYSA-N methylcarbamic acid Chemical compound CNC(O)=O UFEJKYYYVXYMMS-UHFFFAOYSA-N 0.000 claims description 2
- 210000003205 muscle Anatomy 0.000 claims description 2
- 150000002902 organometallic compounds Chemical class 0.000 claims description 2
- 125000001436 propyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])[H] 0.000 claims description 2
- 230000002040 relaxant effect Effects 0.000 claims description 2
- PIICEJLVQHRZGT-UHFFFAOYSA-N Ethylenediamine Chemical compound NCCN PIICEJLVQHRZGT-UHFFFAOYSA-N 0.000 claims 4
- NQRYJNQNLNOLGT-UHFFFAOYSA-N Piperidine Chemical compound C1CCNCC1 NQRYJNQNLNOLGT-UHFFFAOYSA-N 0.000 claims 4
- 125000000954 2-hydroxyethyl group Chemical group [H]C([*])([H])C([H])([H])O[H] 0.000 claims 2
- WGQKYBSKWIADBV-UHFFFAOYSA-N benzylamine Chemical compound NCC1=CC=CC=C1 WGQKYBSKWIADBV-UHFFFAOYSA-N 0.000 claims 2
- SMQUZDBALVYZAC-UHFFFAOYSA-N salicylaldehyde Chemical compound OC1=CC=CC=C1C=O SMQUZDBALVYZAC-UHFFFAOYSA-N 0.000 claims 2
- RMNNIAMWALNYIB-UHFFFAOYSA-N (4-chlorophenyl)-(4,6-dimethoxy-1-benzofuran-2-yl)methanol Chemical compound O1C2=CC(OC)=CC(OC)=C2C=C1C(O)C1=CC=C(Cl)C=C1 RMNNIAMWALNYIB-UHFFFAOYSA-N 0.000 claims 1
- QPPXFJOXEQTFQZ-UHFFFAOYSA-N (4-chlorophenyl)-(7-methoxy-1-benzofuran-2-yl)methanone Chemical compound O1C=2C(OC)=CC=CC=2C=C1C(=O)C1=CC=C(Cl)C=C1 QPPXFJOXEQTFQZ-UHFFFAOYSA-N 0.000 claims 1
- IWXLLFHWZXXAAV-UHFFFAOYSA-N (7-ethoxy-1-benzofuran-2-yl)-(4-nitrophenyl)methanone Chemical compound O1C=2C(OCC)=CC=CC=2C=C1C(=O)C1=CC=C([N+]([O-])=O)C=C1 IWXLLFHWZXXAAV-UHFFFAOYSA-N 0.000 claims 1
- GRVNOUKHAZXMJK-UHFFFAOYSA-N 1-[(2-methylphenyl)methyl]piperazine Chemical compound CC1=CC=CC=C1CN1CCNCC1 GRVNOUKHAZXMJK-UHFFFAOYSA-N 0.000 claims 1
- TVONMLOGRLGDHE-UHFFFAOYSA-N 1-benzofuran-2-yl-(4-methylphenyl)methanol Chemical compound C1=CC(C)=CC=C1C(O)C1=CC2=CC=CC=C2O1 TVONMLOGRLGDHE-UHFFFAOYSA-N 0.000 claims 1
- VJNLJXCAPIBQSI-UHFFFAOYSA-N 1-benzyl-4-chloropiperazine Chemical compound C1CN(Cl)CCN1CC1=CC=CC=C1 VJNLJXCAPIBQSI-UHFFFAOYSA-N 0.000 claims 1
- IQXXEPZFOOTTBA-UHFFFAOYSA-N 1-benzylpiperazine Chemical compound C=1C=CC=CC=1CN1CCNCC1 IQXXEPZFOOTTBA-UHFFFAOYSA-N 0.000 claims 1
- HPWVULXMORCLSH-UHFFFAOYSA-N 2-(4-chlorophenyl)-1-methylpiperidine Chemical compound CN1CCCCC1C1=CC=C(Cl)C=C1 HPWVULXMORCLSH-UHFFFAOYSA-N 0.000 claims 1
- 125000002941 2-furyl group Chemical group O1C([*])=C([H])C([H])=C1[H] 0.000 claims 1
- 125000001255 4-fluorophenyl group Chemical group [H]C1=C([H])C(*)=C([H])C([H])=C1F 0.000 claims 1
- UZFMOKQJFYMBGY-UHFFFAOYSA-N 4-hydroxy-TEMPO Chemical compound CC1(C)CC(O)CC(C)(C)N1[O] UZFMOKQJFYMBGY-UHFFFAOYSA-N 0.000 claims 1
- 150000001412 amines Chemical class 0.000 claims 1
- 230000003042 antagnostic effect Effects 0.000 claims 1
- 230000001708 anti-dyslipidemic effect Effects 0.000 claims 1
- RWCCWEUUXYIKHB-UHFFFAOYSA-N benzophenone Chemical compound C=1C=CC=CC=1C(=O)C1=CC=CC=C1 RWCCWEUUXYIKHB-UHFFFAOYSA-N 0.000 claims 1
- 239000010200 folin Substances 0.000 claims 1
- 238000009472 formulation Methods 0.000 claims 1
- 150000004820 halides Chemical class 0.000 claims 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 claims 1
- 125000004573 morpholin-4-yl group Chemical group N1(CCOCC1)* 0.000 claims 1
- ACYBVNYNIZTUIL-UHFFFAOYSA-N n'-benzylethane-1,2-diamine Chemical compound NCCNCC1=CC=CC=C1 ACYBVNYNIZTUIL-UHFFFAOYSA-N 0.000 claims 1
- AOHJOMMDDJHIJH-UHFFFAOYSA-N propylenediamine Chemical compound CC(N)CN AOHJOMMDDJHIJH-UHFFFAOYSA-N 0.000 claims 1
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 25
- 238000005160 1H NMR spectroscopy Methods 0.000 description 19
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 14
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 12
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 9
- RYHBNJHYFVUHQT-UHFFFAOYSA-N 1,4-Dioxane Chemical compound C1COCCO1 RYHBNJHYFVUHQT-UHFFFAOYSA-N 0.000 description 7
- PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 description 7
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 6
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 6
- 125000000956 methoxy group Chemical group [H]C([H])([H])O* 0.000 description 6
- MXOAEAUPQDYUQM-UHFFFAOYSA-N chlorphenesin Chemical group OCC(O)COC1=CC=C(Cl)C=C1 MXOAEAUPQDYUQM-UHFFFAOYSA-N 0.000 description 5
- 238000006722 reduction reaction Methods 0.000 description 5
- 239000002904 solvent Substances 0.000 description 5
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 4
- 230000008018 melting Effects 0.000 description 4
- 238000002844 melting Methods 0.000 description 4
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 3
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 3
- YVPJCJLMRRTDMQ-UHFFFAOYSA-N ethyl diazoacetate Chemical compound CCOC(=O)C=[N+]=[N-] YVPJCJLMRRTDMQ-UHFFFAOYSA-N 0.000 description 3
- 229960004592 isopropanol Drugs 0.000 description 3
- 239000012071 phase Substances 0.000 description 3
- 239000002244 precipitate Substances 0.000 description 3
- 229910052938 sodium sulfate Inorganic materials 0.000 description 3
- 235000011152 sodium sulphate Nutrition 0.000 description 3
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 3
- IANQTJSKSUMEQM-UHFFFAOYSA-N 1-benzofuran Chemical compound C1=CC=C2OC=CC2=C1 IANQTJSKSUMEQM-UHFFFAOYSA-N 0.000 description 2
- BMYNFMYTOJXKLE-UHFFFAOYSA-N 3-azaniumyl-2-hydroxypropanoate Chemical compound NCC(O)C(O)=O BMYNFMYTOJXKLE-UHFFFAOYSA-N 0.000 description 2
- VZCYOOQTPOCHFL-OWOJBTEDSA-N Fumaric acid Chemical compound OC(=O)\C=C\C(O)=O VZCYOOQTPOCHFL-OWOJBTEDSA-N 0.000 description 2
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 2
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 2
- AFVFQIVMOAPDHO-UHFFFAOYSA-N Methanesulfonic acid Chemical compound CS(O)(=O)=O AFVFQIVMOAPDHO-UHFFFAOYSA-N 0.000 description 2
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 2
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 2
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 2
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 2
- HEDRZPFGACZZDS-MICDWDOJSA-N Trichloro(2H)methane Chemical compound [2H]C(Cl)(Cl)Cl HEDRZPFGACZZDS-MICDWDOJSA-N 0.000 description 2
- 239000002253 acid Substances 0.000 description 2
- 150000007513 acids Chemical class 0.000 description 2
- 239000002585 base Substances 0.000 description 2
- MFMVRILBADIIJO-UHFFFAOYSA-N benzo[e][1]benzofuran Chemical compound C1=CC=C2C(C=CO3)=C3C=CC2=C1 MFMVRILBADIIJO-UHFFFAOYSA-N 0.000 description 2
- WPYMKLBDIGXBTP-UHFFFAOYSA-N benzoic acid Chemical compound OC(=O)C1=CC=CC=C1 WPYMKLBDIGXBTP-UHFFFAOYSA-N 0.000 description 2
- 230000005587 bubbling Effects 0.000 description 2
- 238000006243 chemical reaction Methods 0.000 description 2
- 239000012458 free base Substances 0.000 description 2
- 239000007789 gas Substances 0.000 description 2
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 2
- 150000007522 mineralic acids Chemical class 0.000 description 2
- 150000007524 organic acids Chemical class 0.000 description 2
- 239000000546 pharmaceutical excipient Substances 0.000 description 2
- 239000000825 pharmaceutical preparation Substances 0.000 description 2
- 230000000144 pharmacologic effect Effects 0.000 description 2
- 229910052698 phosphorus Inorganic materials 0.000 description 2
- 239000011574 phosphorus Substances 0.000 description 2
- 238000010992 reflux Methods 0.000 description 2
- YGSDEFSMJLZEOE-UHFFFAOYSA-N salicylic acid Chemical compound OC(=O)C1=CC=CC=C1O YGSDEFSMJLZEOE-UHFFFAOYSA-N 0.000 description 2
- 239000012279 sodium borohydride Substances 0.000 description 2
- 229910000033 sodium borohydride Inorganic materials 0.000 description 2
- 229910052717 sulfur Inorganic materials 0.000 description 2
- FYSNRJHAOHDILO-UHFFFAOYSA-N thionyl chloride Chemical compound ClS(Cl)=O FYSNRJHAOHDILO-UHFFFAOYSA-N 0.000 description 2
- VZCYOOQTPOCHFL-UHFFFAOYSA-N trans-butenedioic acid Natural products OC(=O)C=CC(O)=O VZCYOOQTPOCHFL-UHFFFAOYSA-N 0.000 description 2
- 238000005406 washing Methods 0.000 description 2
- UQMOUHJLYOWVID-UHFFFAOYSA-N (4-chlorophenyl)-(3-methyl-1-benzofuran-2-yl)methanol Chemical group O1C2=CC=CC=C2C(C)=C1C(O)C1=CC=C(Cl)C=C1 UQMOUHJLYOWVID-UHFFFAOYSA-N 0.000 description 1
- JDUCKRYGJXERSU-UHFFFAOYSA-N (4-chlorophenyl)-(7-ethoxy-1-benzofuran-2-yl)methanol Chemical group O1C=2C(OCC)=CC=CC=2C=C1C(O)C1=CC=C(Cl)C=C1 JDUCKRYGJXERSU-UHFFFAOYSA-N 0.000 description 1
- FDJFSQBODDLOFX-UHFFFAOYSA-N (5-bromo-1-benzofuran-2-yl)-(4-chlorophenyl)methanol Chemical group C=1C2=CC(Br)=CC=C2OC=1C(O)C1=CC=C(Cl)C=C1 FDJFSQBODDLOFX-UHFFFAOYSA-N 0.000 description 1
- GYWZTQBPGMBXHH-UHFFFAOYSA-N (5-bromo-1-benzofuran-2-yl)-phenylmethanone Chemical compound C=1C2=CC(Br)=CC=C2OC=1C(=O)C1=CC=CC=C1 GYWZTQBPGMBXHH-UHFFFAOYSA-N 0.000 description 1
- GSBHFRGDXKZSBY-UHFFFAOYSA-N 1-(4-chlorophenyl)-1-(7-ethoxy-1-benzofuran-2-yl)-2-phenylethanol Chemical group O1C=2C(OCC)=CC=CC=2C=C1C(O)(C=1C=CC(Cl)=CC=1)CC1=CC=CC=C1 GSBHFRGDXKZSBY-UHFFFAOYSA-N 0.000 description 1
- PVOAHINGSUIXLS-UHFFFAOYSA-N 1-Methylpiperazine Chemical compound CN1CCNCC1 PVOAHINGSUIXLS-UHFFFAOYSA-N 0.000 description 1
- LWQVYRAYJOCEDD-UHFFFAOYSA-N 1-[1-benzofuran-2-yl(phenyl)methyl]-4-methylpiperazine Chemical group C1CN(C)CCN1C(C=1C=CC=CC=1)C1=CC2=CC=CC=C2O1 LWQVYRAYJOCEDD-UHFFFAOYSA-N 0.000 description 1
- WKZLGWXYFIHKKF-UHFFFAOYSA-N 1-[1-benzofuran-2-yl(phenyl)methyl]-4-pyridin-2-ylpiperazine Chemical group C1CN(C=2N=CC=CC=2)CCN1C(C=1OC2=CC=CC=C2C=1)C1=CC=CC=C1 WKZLGWXYFIHKKF-UHFFFAOYSA-N 0.000 description 1
- XDFPNQOTQXCDKV-UHFFFAOYSA-N 1-[1-benzofuran-2-yl(phenyl)methyl]piperidine Chemical compound C1CCCCN1C(C=1C=CC=CC=1)C1=CC2=CC=CC=C2O1 XDFPNQOTQXCDKV-UHFFFAOYSA-N 0.000 description 1
- TWIZFQOOGBIQIP-UHFFFAOYSA-N 1-[1-benzofuran-2-yl-(4-chlorophenyl)methyl]-4-phenylpiperazine;hydrochloride Chemical group Cl.C1=CC(Cl)=CC=C1C(C=1OC2=CC=CC=C2C=1)N1CCN(C=2C=CC=CC=2)CC1 TWIZFQOOGBIQIP-UHFFFAOYSA-N 0.000 description 1
- AWJSYAKYKRYQGF-UHFFFAOYSA-N 1-[1-benzofuran-2-yl-(4-chlorophenyl)methyl]piperidine Chemical group C1=CC(Cl)=CC=C1C(C=1OC2=CC=CC=C2C=1)N1CCCCC1 AWJSYAKYKRYQGF-UHFFFAOYSA-N 0.000 description 1
- BWVKPRJZQROGIQ-UHFFFAOYSA-N 1-[1-benzofuran-2-yl-(4-methylphenyl)methyl]-4-methylpiperazine;hydrochloride Chemical group Cl.C1CN(C)CCN1C(C=1C=CC(C)=CC=1)C1=CC2=CC=CC=C2O1 BWVKPRJZQROGIQ-UHFFFAOYSA-N 0.000 description 1
- UHNONZBXKKRAEE-UHFFFAOYSA-N 1-[1-benzofuran-2-yl-(4-methylphenyl)methyl]piperidine Chemical group C1=CC(C)=CC=C1C(C=1OC2=CC=CC=C2C=1)N1CCCCC1 UHNONZBXKKRAEE-UHFFFAOYSA-N 0.000 description 1
- HMUNWXXNJPVALC-UHFFFAOYSA-N 1-[4-[2-(2,3-dihydro-1H-inden-2-ylamino)pyrimidin-5-yl]piperazin-1-yl]-2-(2,4,6,7-tetrahydrotriazolo[4,5-c]pyridin-5-yl)ethanone Chemical compound C1C(CC2=CC=CC=C12)NC1=NC=C(C=N1)N1CCN(CC1)C(CN1CC2=C(CC1)NN=N2)=O HMUNWXXNJPVALC-UHFFFAOYSA-N 0.000 description 1
- FQHJAAOLWZILJU-UHFFFAOYSA-N 1-benzofuran-2-yl-(4-chlorophenyl)methanone Chemical compound C1=CC(Cl)=CC=C1C(=O)C1=CC2=CC=CC=C2O1 FQHJAAOLWZILJU-UHFFFAOYSA-N 0.000 description 1
- NIDNSGORHMQLTR-UHFFFAOYSA-N 1-benzofuran-2-yl-(4-fluorophenyl)methanol Chemical group C=1C2=CC=CC=C2OC=1C(O)C1=CC=C(F)C=C1 NIDNSGORHMQLTR-UHFFFAOYSA-N 0.000 description 1
- VPVXOXQYVCWECX-UHFFFAOYSA-N 1-benzofuran-2-yl-(4-nitrophenyl)methanol Chemical group C=1C2=CC=CC=C2OC=1C(O)C1=CC=C([N+]([O-])=O)C=C1 VPVXOXQYVCWECX-UHFFFAOYSA-N 0.000 description 1
- MDHQBLCZIBSPFW-UHFFFAOYSA-N 2-[4-[1-benzofuran-2-yl(phenyl)methyl]piperazin-1-yl]ethanol;hydrochloride Chemical group Cl.C1CN(CCO)CCN1C(C=1C=CC=CC=1)C1=CC2=CC=CC=C2O1 MDHQBLCZIBSPFW-UHFFFAOYSA-N 0.000 description 1
- BPNQEUKXLYMIKP-UHFFFAOYSA-N 2-[chloro(phenyl)methyl]-1-benzofuran Chemical compound C=1C2=CC=CC=C2OC=1C(Cl)C1=CC=CC=C1 BPNQEUKXLYMIKP-UHFFFAOYSA-N 0.000 description 1
- OMCSCCPZCSQESB-UHFFFAOYSA-N 2-[chloro-(4-chlorophenyl)methyl]-1-benzofuran Chemical compound C=1C2=CC=CC=C2OC=1C(Cl)C1=CC=C(Cl)C=C1 OMCSCCPZCSQESB-UHFFFAOYSA-N 0.000 description 1
- FZKXENDBICFRRU-UHFFFAOYSA-N 2-n-[1-benzofuran-2-yl-(4-chlorophenyl)methyl]-1-n,1-n-dimethylpropane-1,2-diamine;hydrochloride Chemical group Cl.C=1C2=CC=CC=C2OC=1C(NC(CN(C)C)C)C1=CC=C(Cl)C=C1 FZKXENDBICFRRU-UHFFFAOYSA-N 0.000 description 1
- OFQBYHLLIJGMNP-UHFFFAOYSA-N 3-ethoxy-2-hydroxybenzaldehyde Chemical compound CCOC1=CC=CC(C=O)=C1O OFQBYHLLIJGMNP-UHFFFAOYSA-N 0.000 description 1
- OKISUZLXOYGIFP-UHFFFAOYSA-N 4,4'-dichlorobenzophenone Chemical group C1=CC(Cl)=CC=C1C(=O)C1=CC=C(Cl)C=C1 OKISUZLXOYGIFP-UHFFFAOYSA-N 0.000 description 1
- RZTINMGYAUPPMB-UHFFFAOYSA-N 4-[1-benzofuran-2-yl-(4-methylphenyl)methyl]morpholine;hydrochloride Chemical group Cl.C1=CC(C)=CC=C1C(C=1OC2=CC=CC=C2C=1)N1CCOCC1 RZTINMGYAUPPMB-UHFFFAOYSA-N 0.000 description 1
- KMTDMTZBNYGUNX-UHFFFAOYSA-N 4-methylbenzyl alcohol Chemical compound CC1=CC=C(CO)C=C1 KMTDMTZBNYGUNX-UHFFFAOYSA-N 0.000 description 1
- ZCYVEMRRCGMTRW-UHFFFAOYSA-N 7553-56-2 Chemical compound [I] ZCYVEMRRCGMTRW-UHFFFAOYSA-N 0.000 description 1
- 239000005711 Benzoic acid Substances 0.000 description 1
- WKBOTKDWSSQWDR-UHFFFAOYSA-N Bromine atom Chemical compound [Br] WKBOTKDWSSQWDR-UHFFFAOYSA-N 0.000 description 1
- ZIJCSOPWDDXJLH-UHFFFAOYSA-N C(C)O[AlH]OCC.[Na] Chemical compound C(C)O[AlH]OCC.[Na] ZIJCSOPWDDXJLH-UHFFFAOYSA-N 0.000 description 1
- UXVMQQNJUSDDNG-UHFFFAOYSA-L Calcium chloride Chemical compound [Cl-].[Cl-].[Ca+2] UXVMQQNJUSDDNG-UHFFFAOYSA-L 0.000 description 1
- MPOSBVXILNWDKW-UHFFFAOYSA-N Cl.Cl.OC(CN1CCN(CC1)C(C1=CC=C(C=C1)Cl)C=1OC2=C(C1)C=CC=C2)C Chemical group Cl.Cl.OC(CN1CCN(CC1)C(C1=CC=C(C=C1)Cl)C=1OC2=C(C1)C=CC=C2)C MPOSBVXILNWDKW-UHFFFAOYSA-N 0.000 description 1
- RHRZOHCAEGZVJI-UHFFFAOYSA-N Cl.Cl.OC(CN1CCN(CC1)C(C1=CC=CC=C1)C=1OC2=C(C1)C=CC=C2)C Chemical group Cl.Cl.OC(CN1CCN(CC1)C(C1=CC=CC=C1)C=1OC2=C(C1)C=CC=C2)C RHRZOHCAEGZVJI-UHFFFAOYSA-N 0.000 description 1
- OEIJOSJLTWPTEI-UHFFFAOYSA-N Cl.OCCN1CCN(CC1)C(C1=CC=C(C=C1)Cl)C=1OC2=C(C1)C=CC=C2 Chemical group Cl.OCCN1CCN(CC1)C(C1=CC=C(C=C1)Cl)C=1OC2=C(C1)C=CC=C2 OEIJOSJLTWPTEI-UHFFFAOYSA-N 0.000 description 1
- XDTMQSROBMDMFD-UHFFFAOYSA-N Cyclohexane Chemical compound C1CCCCC1 XDTMQSROBMDMFD-UHFFFAOYSA-N 0.000 description 1
- FEWJPZIEWOKRBE-JCYAYHJZSA-N Dextrotartaric acid Chemical compound OC(=O)[C@H](O)[C@@H](O)C(O)=O FEWJPZIEWOKRBE-JCYAYHJZSA-N 0.000 description 1
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- 238000005481 NMR spectroscopy Methods 0.000 description 1
- RSXLEFSEOQAGCB-UHFFFAOYSA-N O.Cl.Cl.O1C(=CC2=C1C=CC=C2)NCC2=CC=C(C=C2)Cl Chemical group O.Cl.Cl.O1C(=CC2=C1C=CC=C2)NCC2=CC=C(C=C2)Cl RSXLEFSEOQAGCB-UHFFFAOYSA-N 0.000 description 1
- OFOBLEOULBTSOW-UHFFFAOYSA-N Propanedioic acid Natural products OC(=O)CC(O)=O OFOBLEOULBTSOW-UHFFFAOYSA-N 0.000 description 1
- 239000007868 Raney catalyst Substances 0.000 description 1
- NPXOKRUENSOPAO-UHFFFAOYSA-N Raney nickel Chemical compound [Al].[Ni] NPXOKRUENSOPAO-UHFFFAOYSA-N 0.000 description 1
- 229910000564 Raney nickel Inorganic materials 0.000 description 1
- FEWJPZIEWOKRBE-UHFFFAOYSA-N Tartaric acid Natural products [H+].[H+].[O-]C(=O)C(O)C(O)C([O-])=O FEWJPZIEWOKRBE-UHFFFAOYSA-N 0.000 description 1
- GUGOEEXESWIERI-UHFFFAOYSA-N Terfenadine Chemical compound C1=CC(C(C)(C)C)=CC=C1C(O)CCCN1CCC(C(O)(C=2C=CC=CC=2)C=2C=CC=CC=2)CC1 GUGOEEXESWIERI-UHFFFAOYSA-N 0.000 description 1
- ATJFFYVFTNAWJD-UHFFFAOYSA-N Tin Chemical compound [Sn] ATJFFYVFTNAWJD-UHFFFAOYSA-N 0.000 description 1
- 235000011054 acetic acid Nutrition 0.000 description 1
- 239000004480 active ingredient Substances 0.000 description 1
- 150000001299 aldehydes Chemical class 0.000 description 1
- 150000001350 alkyl halides Chemical class 0.000 description 1
- SMZOGRDCAXLAAR-UHFFFAOYSA-N aluminium isopropoxide Chemical compound [Al+3].CC(C)[O-].CC(C)[O-].CC(C)[O-] SMZOGRDCAXLAAR-UHFFFAOYSA-N 0.000 description 1
- 229910000147 aluminium phosphate Inorganic materials 0.000 description 1
- 239000005557 antagonist Substances 0.000 description 1
- 230000002402 anti-lipaemic effect Effects 0.000 description 1
- XGRFEZNNLHUZFB-UHFFFAOYSA-N benzo[e][1]benzofuran-2-yl(phenyl)methanone Chemical group C=1C(C2=CC=CC=C2C=C2)=C2OC=1C(=O)C1=CC=CC=C1 XGRFEZNNLHUZFB-UHFFFAOYSA-N 0.000 description 1
- 235000010233 benzoic acid Nutrition 0.000 description 1
- 230000037396 body weight Effects 0.000 description 1
- GDTBXPJZTBHREO-UHFFFAOYSA-N bromine Substances BrBr GDTBXPJZTBHREO-UHFFFAOYSA-N 0.000 description 1
- 229910052794 bromium Inorganic materials 0.000 description 1
- 239000001110 calcium chloride Substances 0.000 description 1
- 235000011148 calcium chloride Nutrition 0.000 description 1
- 229910001628 calcium chloride Inorganic materials 0.000 description 1
- 239000002775 capsule Substances 0.000 description 1
- 125000002915 carbonyl group Chemical group [*:2]C([*:1])=O 0.000 description 1
- 239000000969 carrier Substances 0.000 description 1
- 239000003054 catalyst Substances 0.000 description 1
- 238000010531 catalytic reduction reaction Methods 0.000 description 1
- 239000003638 chemical reducing agent Substances 0.000 description 1
- 238000002425 crystallisation Methods 0.000 description 1
- 230000008025 crystallization Effects 0.000 description 1
- 239000008298 dragée Substances 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 239000001530 fumaric acid Substances 0.000 description 1
- 235000011087 fumaric acid Nutrition 0.000 description 1
- 229910052736 halogen Inorganic materials 0.000 description 1
- 230000002140 halogenating effect Effects 0.000 description 1
- 150000002367 halogens Chemical class 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- XMBWDFGMSWQBCA-UHFFFAOYSA-N hydrogen iodide Chemical compound I XMBWDFGMSWQBCA-UHFFFAOYSA-N 0.000 description 1
- 229940071870 hydroiodic acid Drugs 0.000 description 1
- JXYZHMPRERWTPM-UHFFFAOYSA-N hydron;morpholine;chloride Chemical group Cl.C1COCCN1 JXYZHMPRERWTPM-UHFFFAOYSA-N 0.000 description 1
- CVVIJWRCGSYCMB-UHFFFAOYSA-N hydron;piperazine;dichloride Chemical group Cl.Cl.C1CNCCN1 CVVIJWRCGSYCMB-UHFFFAOYSA-N 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- 239000011630 iodine Substances 0.000 description 1
- 229910052740 iodine Inorganic materials 0.000 description 1
- INQOMBQAUSQDDS-UHFFFAOYSA-N iodomethane Chemical compound IC INQOMBQAUSQDDS-UHFFFAOYSA-N 0.000 description 1
- 229910052742 iron Inorganic materials 0.000 description 1
- 239000004310 lactic acid Substances 0.000 description 1
- 235000014655 lactic acid Nutrition 0.000 description 1
- 239000012280 lithium aluminium hydride Substances 0.000 description 1
- 239000011777 magnesium Substances 0.000 description 1
- 229910052749 magnesium Inorganic materials 0.000 description 1
- VZCYOOQTPOCHFL-UPHRSURJSA-N maleic acid Chemical compound OC(=O)\C=C/C(O)=O VZCYOOQTPOCHFL-UPHRSURJSA-N 0.000 description 1
- 239000011976 maleic acid Substances 0.000 description 1
- 229910052751 metal Inorganic materials 0.000 description 1
- 239000002184 metal Substances 0.000 description 1
- 229910052987 metal hydride Inorganic materials 0.000 description 1
- 150000004681 metal hydrides Chemical class 0.000 description 1
- UKVIEHSSVKSQBA-UHFFFAOYSA-N methane;palladium Chemical compound C.[Pd] UKVIEHSSVKSQBA-UHFFFAOYSA-N 0.000 description 1
- 229940098779 methanesulfonic acid Drugs 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 235000010755 mineral Nutrition 0.000 description 1
- ZQHKMWSEHQBRFM-UHFFFAOYSA-N n'-[1-benzofuran-2-yl-(4-chlorophenyl)methyl]-n,n,n'-trimethylethane-1,2-diamine;hydrate;dihydrochloride Chemical group O.Cl.Cl.C=1C2=CC=CC=C2OC=1C(N(C)CCN(C)C)C1=CC=C(Cl)C=C1 ZQHKMWSEHQBRFM-UHFFFAOYSA-N 0.000 description 1
- ZJPBJPCJQDNKRD-UHFFFAOYSA-N n'-methyl-n'-phenylethane-1,2-diamine;hydrochloride Chemical group Cl.NCCN(C)C1=CC=CC=C1 ZJPBJPCJQDNKRD-UHFFFAOYSA-N 0.000 description 1
- FXUICQGVHKBCMH-UHFFFAOYSA-N n-[(5-bromo-1-benzofuran-2-yl)-phenylmethyl]-n',n'-dimethylethane-1,2-diamine;dihydrochloride Chemical compound Cl.Cl.C=1C2=CC(Br)=CC=C2OC=1C(NCCN(C)C)C1=CC=CC=C1 FXUICQGVHKBCMH-UHFFFAOYSA-N 0.000 description 1
- YTOXMHKLHLLOMA-UHFFFAOYSA-N n-[1-benzofuran-2-yl(phenyl)methyl]-n',n'-dimethylethane-1,2-diamine;hydrochloride Chemical group Cl.C=1C2=CC=CC=C2OC=1C(NCCN(C)C)C1=CC=CC=C1 YTOXMHKLHLLOMA-UHFFFAOYSA-N 0.000 description 1
- ZBTLWUKTKYPIAM-UHFFFAOYSA-N n-[1-benzofuran-2-yl-(4-chlorophenyl)methyl]-n',n'-dimethylethane-1,2-diamine;hydrochloride Chemical compound Cl.C=1C2=CC=CC=C2OC=1C(NCCN(C)C)C1=CC=C(Cl)C=C1 ZBTLWUKTKYPIAM-UHFFFAOYSA-N 0.000 description 1
- YPQAMVIYKAVCAP-UHFFFAOYSA-N n-[1-benzofuran-2-yl-(4-chlorophenyl)methyl]propan-2-amine;hydrochloride Chemical group Cl.C=1C2=CC=CC=C2OC=1C(NC(C)C)C1=CC=C(Cl)C=C1 YPQAMVIYKAVCAP-UHFFFAOYSA-N 0.000 description 1
- 231100000252 nontoxic Toxicity 0.000 description 1
- 230000003000 nontoxic effect Effects 0.000 description 1
- 235000005985 organic acids Nutrition 0.000 description 1
- 239000012074 organic phase Substances 0.000 description 1
- FJKROLUGYXJWQN-UHFFFAOYSA-N papa-hydroxy-benzoic acid Natural products OC(=O)C1=CC=C(O)C=C1 FJKROLUGYXJWQN-UHFFFAOYSA-N 0.000 description 1
- 238000007911 parenteral administration Methods 0.000 description 1
- 239000003208 petroleum Substances 0.000 description 1
- UHZYTMXLRWXGPK-UHFFFAOYSA-N phosphorus pentachloride Chemical compound ClP(Cl)(Cl)(Cl)Cl UHZYTMXLRWXGPK-UHFFFAOYSA-N 0.000 description 1
- FAIAAWCVCHQXDN-UHFFFAOYSA-N phosphorus trichloride Chemical compound ClP(Cl)Cl FAIAAWCVCHQXDN-UHFFFAOYSA-N 0.000 description 1
- 239000006187 pill Substances 0.000 description 1
- BASFCYQUMIYNBI-UHFFFAOYSA-N platinum Chemical compound [Pt] BASFCYQUMIYNBI-UHFFFAOYSA-N 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 229960004889 salicylic acid Drugs 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 235000017557 sodium bicarbonate Nutrition 0.000 description 1
- 229910000030 sodium bicarbonate Inorganic materials 0.000 description 1
- 235000011121 sodium hydroxide Nutrition 0.000 description 1
- 239000007858 starting material Substances 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 150000003467 sulfuric acid derivatives Chemical class 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 238000010189 synthetic method Methods 0.000 description 1
- 239000003826 tablet Substances 0.000 description 1
- 239000011975 tartaric acid Substances 0.000 description 1
- 235000002906 tartaric acid Nutrition 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D307/92—Naphthofurans; Hydrogenated naphthofurans
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
- A61P21/02—Muscle relaxants, e.g. for tetanus or cramps
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/06—Antiarrhythmics
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D307/78—Benzo [b] furans; Hydrogenated benzo [b] furans
- C07D307/79—Benzo [b] furans; Hydrogenated benzo [b] furans with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to carbon atoms of the hetero ring
- C07D307/80—Radicals substituted by oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D307/78—Benzo [b] furans; Hydrogenated benzo [b] furans
- C07D307/79—Benzo [b] furans; Hydrogenated benzo [b] furans with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to carbon atoms of the hetero ring
- C07D307/81—Radicals substituted by nitrogen atoms not forming part of a nitro radical
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D307/78—Benzo [b] furans; Hydrogenated benzo [b] furans
- C07D307/86—Benzo [b] furans; Hydrogenated benzo [b] furans with an oxygen atom directly attached in position 7
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Engineering & Computer Science (AREA)
- Neurology (AREA)
- Heart & Thoracic Surgery (AREA)
- Pain & Pain Management (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Biomedical Technology (AREA)
- Cardiology (AREA)
- Neurosurgery (AREA)
- Diabetes (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Physical Education & Sports Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Furan Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IT09583/80A IT1154888B (it) | 1980-11-12 | 1980-11-12 | Derivati del benzofurano 2-sostituiti e relativi metodi di preparazione |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| SE8106733L SE8106733L (sv) | 1982-05-13 |
| SE451328B true SE451328B (sv) | 1987-09-28 |
Family
ID=11132470
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SE8106733A SE451328B (sv) | 1980-11-12 | 1981-11-12 | 2-substituerade bensofuranderivat, forfarande for deras framstellning samt farmaceutiska kompositioner innehallande nemnda derivat |
Country Status (14)
| Country | Link |
|---|---|
| US (2) | US4485112A (en, 2012) |
| JP (1) | JPS57109774A (en, 2012) |
| BE (1) | BE891092A (en, 2012) |
| CA (1) | CA1182454A (en, 2012) |
| CH (1) | CH653679A5 (en, 2012) |
| DE (1) | DE3145004A1 (en, 2012) |
| DK (1) | DK153788C (en, 2012) |
| ES (1) | ES8307781A1 (en, 2012) |
| FR (1) | FR2493845B1 (en, 2012) |
| GB (1) | GB2091719B (en, 2012) |
| GR (1) | GR76933B (en, 2012) |
| IT (1) | IT1154888B (en, 2012) |
| NL (1) | NL8105121A (en, 2012) |
| SE (1) | SE451328B (en, 2012) |
Families Citing this family (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2550091B1 (fr) * | 1983-08-02 | 1986-05-23 | Sanofi Sa | Composition pharmaceutique ou veterinaire destinee a combattre des troubles ischemiques cardiaques contenant un derive du benzofuranne |
| US5087638A (en) * | 1984-06-20 | 1992-02-11 | Merck Frosst Canada, Inc. | Benzofuran derivatives |
| CA1281325C (en) * | 1984-06-20 | 1991-03-12 | Patrice C. Belanger | Benzofuran derivatives |
| IT1216256B (it) * | 1986-08-13 | 1990-02-22 | Menarini Sas | (benzofuran-2-il) imidazoli, con attivita' farmacologica,loro sali e procedimenti di fabbricazione relativi. |
| US4956382A (en) * | 1987-02-07 | 1990-09-11 | Pfizer Inc. | Sulfonamide anti-arrhythmic agents |
| US4851554A (en) * | 1987-04-06 | 1989-07-25 | University Of Tennessee Research Corporation | Certain 3-substituted 2-alkyl benzofuran derivatives |
| US4806663A (en) * | 1987-04-06 | 1989-02-21 | The University Of Tennessee Research Corporation | Certain 3-substituted 2-alkyl benzofuran derivatives |
| US4831156A (en) * | 1987-09-30 | 1989-05-16 | The University Of Tennessee Research Corp. | 3-substituted 2-alkyl indole derivatives |
| WO1989002893A1 (en) * | 1987-09-30 | 1989-04-06 | The University Of Tennessee Research Corporation | Certain 3-substituted 2-alkyl benzothiophene derivatives |
| US4975458A (en) * | 1989-03-13 | 1990-12-04 | Taro Pharmaceuticals Industries, Ltd. | 2-alkyl-3-benzoylbenzofurans useful for treating cardiac arrhythmia |
| WO1993001180A1 (en) * | 1991-07-09 | 1993-01-21 | Nippon Shinyaku Co., Ltd. | Benzofuran derivative and pharmaceutical composition |
| FR2708609B1 (fr) * | 1993-07-29 | 1995-10-20 | Sanofi Elf | Dérivés de méthylguanidine, leurs procédés de préparation ainsi que les compositions en contenant. |
| US6653328B1 (en) * | 1995-03-10 | 2003-11-25 | Eli Lilly And Company | 3-benzyl-benzothiophenes |
| US6417199B1 (en) * | 1995-03-10 | 2002-07-09 | Eli Lilly And Company | 3-benzyl-benzothiophenes |
| US6395755B1 (en) * | 1995-03-10 | 2002-05-28 | Eli Lilly And Company | Benzothiophene pharmaceutical compounds |
| WO2004026253A2 (en) * | 2002-09-17 | 2004-04-01 | Arqule, Inc. | Novel lapacho compounds and methods of use thereof |
| EP2447263A1 (en) | 2010-09-27 | 2012-05-02 | Bioprojet | Benzazole derivatives as histamine H4 receptor ligands |
| WO2019195118A1 (en) * | 2018-04-03 | 2019-10-10 | Children's Hospital Medical Center | Inhibitors of eya3-protein tyrosine phosphatase in dna damage repair signaling of pulmonary arterial hypertension |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3156688A (en) * | 1962-11-05 | 1964-11-10 | Abbott Lab | Nu-alkyl and nu-aralkyl benzoxacycloalkanemethylamines |
| DE1492403A1 (de) * | 1965-03-30 | 1969-12-04 | Merck Ag E | UV-Lichtschutzmittel fuer kosmetische Zwecke |
| GB1160925A (en) * | 1967-02-08 | 1969-08-06 | Menarini Sas | 2-Substituted Benzofuran Derivatives |
| US3880891A (en) * | 1973-09-21 | 1975-04-29 | Smithkline Corp | Substituted benzofurans |
| US4024273A (en) * | 1974-06-20 | 1977-05-17 | Smithkline Corporation | Coronary vasodilator and anti-anginal compositions comprising substituted benzofurans and benzothiophenes and methods of producing coronary vasodilation and anti-anginal activity |
| US3983245A (en) * | 1975-02-06 | 1976-09-28 | Smithkline Corporation | Certain 4-(3-azacycloalkoxy or azacycloalkylmethoxy)benzoylbenzofurans or benzothiophenes |
-
1980
- 1980-11-12 IT IT09583/80A patent/IT1154888B/it active
-
1981
- 1981-03-06 GB GB8107130A patent/GB2091719B/en not_active Expired
- 1981-11-12 DE DE19813145004 patent/DE3145004A1/de not_active Withdrawn
- 1981-11-12 CA CA000389931A patent/CA1182454A/en not_active Expired
- 1981-11-12 GR GR66504A patent/GR76933B/el unknown
- 1981-11-12 JP JP56180430A patent/JPS57109774A/ja active Granted
- 1981-11-12 SE SE8106733A patent/SE451328B/sv not_active IP Right Cessation
- 1981-11-12 BE BE0/206522A patent/BE891092A/fr not_active IP Right Cessation
- 1981-11-12 NL NL8105121A patent/NL8105121A/nl not_active Application Discontinuation
- 1981-11-12 CH CH7276/81A patent/CH653679A5/it not_active IP Right Cessation
- 1981-11-12 DK DK501181A patent/DK153788C/da active
- 1981-11-12 FR FR8121192A patent/FR2493845B1/fr not_active Expired
- 1981-11-12 ES ES507072A patent/ES8307781A1/es not_active Expired
-
1983
- 1983-02-22 US US06/468,869 patent/US4485112A/en not_active Expired - Fee Related
-
1984
- 1984-08-17 US US06/641,606 patent/US4604392A/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| US4485112A (en) | 1984-11-27 |
| GB2091719A (en) | 1982-08-04 |
| ES507072A0 (es) | 1983-08-16 |
| JPH0245629B2 (en, 2012) | 1990-10-11 |
| BE891092A (fr) | 1982-03-01 |
| DE3145004A1 (de) | 1982-06-16 |
| ES8307781A1 (es) | 1983-08-16 |
| IT8009583A0 (it) | 1980-11-12 |
| DK153788B (da) | 1988-09-05 |
| DK501181A (da) | 1982-05-13 |
| SE8106733L (sv) | 1982-05-13 |
| FR2493845A1 (fr) | 1982-05-14 |
| DK153788C (da) | 1989-01-23 |
| CA1182454A (en) | 1985-02-12 |
| GR76933B (en, 2012) | 1984-09-04 |
| FR2493845B1 (fr) | 1985-07-05 |
| JPS57109774A (en) | 1982-07-08 |
| GB2091719B (en) | 1985-06-05 |
| NL8105121A (nl) | 1982-06-01 |
| CH653679A5 (it) | 1986-01-15 |
| IT1154888B (it) | 1987-01-21 |
| US4604392A (en) | 1986-08-05 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| SE451328B (sv) | 2-substituerade bensofuranderivat, forfarande for deras framstellning samt farmaceutiska kompositioner innehallande nemnda derivat | |
| US4590196A (en) | Analgesic 1,2-benzisothiazol-3-ylpiperazine derivatives | |
| CA1190224A (en) | Derivatives of 1,2-diamino-cyclobutene-3,4-dione as potent histamine h.sub.2-antagonists | |
| DK156825B (da) | Analogifremgangsmaade til fremstilling af en basisk ether eller et farmaceutisk acceptabelt syreadditionssalt eller kvaternaert salt deraf | |
| US3974156A (en) | 2-(Substituted anilino) methylmorpholine compounds | |
| US5352678A (en) | Antiischemic piperazinyl- and piperidinyl-cyclohexanes | |
| US3071618A (en) | Diquaternary ammonium salts of n, n, n', n'-tetra substituted alkylene diamines | |
| US2628973A (en) | Aryloxyacetates of basically substituted arylakanols and derivatives thereof | |
| NO126914B (en, 2012) | ||
| US3043844A (en) | Lower-alkyl 1-[3-(monocarbocyclic-aryl)-2-propenyl]-4-phenyl-4-piperidyl ketones and their preparation | |
| US3989722A (en) | 1-Aminomethyl-2,2-diaryl-cyclopropane carboxamides | |
| US2776282A (en) | Cyclic amides of alpha-toluic acids and derivatives thereof | |
| US4140770A (en) | Benzoylethers and processes for their production | |
| US3751390A (en) | Substituted dibenzofuran | |
| US2772289A (en) | Basic esters of n-aralkyl-n-aryl-carbamic acids and the manufacture thereof | |
| US3668206A (en) | Heterocyclic amine derivatives of 5,8-dihydronaphthyloxy propanols | |
| SE448728B (sv) | 4-(naftalenyloxi)piperidin-derivat och en farmaceutisk komposition med antipsykotisk verkan | |
| US3836534A (en) | 5-piperazino-6-hydroxy-5h-benzo-cycloheptenes | |
| US2757177A (en) | Basic derivatives of substituted cycloalkanecarboxylic acids and methods of preparing same | |
| US3701786A (en) | Dibenzofuranyl-aminoalcohols | |
| US2661351A (en) | N-alkyl-9-xanthene-carboxamides, basically substituted derivatives and salts thereof | |
| US3185692A (en) | Aminoalkyl-n-benzodioxyl carbamates | |
| US2971955A (en) | Cyclohexylcarbinol derivatives of piperazine | |
| US3388121A (en) | Tetrahydrobenzocyclohexene and cycloheptene ethers | |
| PL71070B1 (en, 2012) |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| NUG | Patent has lapsed |
Ref document number: 8106733-2 Effective date: 19910611 Format of ref document f/p: F |